ACIU Stock Analysis: Buy, Sell, or Hold?
ACIU - AC Immune SA
$2.22
0.03 (1.37%)
▲
5d:
-3.48%
30d:
-11.55%
90d:
-25.5%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 04, 2026
0d
Get Alerted When ACIU Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ACIU trading at deep discount. Market pricing in -32.8% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: ACIU trading at deep discount. Market pricing in -32.8% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$10.24
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$6.36
65.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ACIU is currently trading at $2.22, which is considered oversold relative to its 30-day fair value range of $2.24 to $2.51. From a valuation perspective, the stock is trading at a discount (Forward PE: 4.5) compared to its historical average (14.8). Remarkably, the market is currently pricing in an annual earnings decline of 32.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ACIU is in a strong downtrend. The price is currently testing key support at $2.16. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.60 (+287.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ACIU is in a strong downtrend. The price is currently testing key support at $2.16. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.60 (+287.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.24 -
$2.51
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 287.2% below Wall St target ($8.60)
Trading Range Analysis
30-Day Trading Range
$2.24 -
$2.51
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.16
Resistance Level
$2.41
Current Trend
Strong Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
4.49
Wall Street Target
$8.60
(+287.2%)
Revenue Growth (YoY)
13.0%
Valuation Discount vs History
-32.8% cheaper
PE vs Historical
4.5 vs 14.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-32.8%
(market-implied from PE analysis)
1-Year Target
$2.00
(-10%)
2-Year Target
$1.80
(-19%)
3-Year Target
$1.62
(-27%)
3-Yr Target (if PE normalizes)
(PE: 4→15)
$5.33
(+140%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 4.5 to 14.8
Stabilization Target:
$7.31
(+229.3%)
PE Expansion Potential:
+229.3%
Share & Embed Analysis
Last updated: August 03, 2026 11:19 PM ET
Data refreshes hourly during market hours. Next update: 12:19 AM
Data refreshes hourly during market hours. Next update: 12:19 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACIU showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$87 | 53 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$196 | 47 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$557 | 49 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 60 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 47 HOLD |
